| RS2473227575 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473227839 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473228114 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473228958 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473240506 |
SI
|
Health Risk |
Likely pathogenic |
SI-related disorder, SI-related disorder |
| RS2473244149 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS2473257377 |
CASR
|
Health Risk |
Pathogenic |
Nephrolithiasis/nephrocalcinosis, Nephrolithiasis/nephrocalcinosis |
| RS2473257829 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2473258053 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473258239 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473258614 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473262415 |
PLOD2
|
Health Risk |
Pathogenic |
— |
| RS2473265518 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2473271217 |
PLOD2
|
Health Risk |
Pathogenic |
— |
| RS2473271725 |
P2RY12
|
Health Risk |
Likely pathogenic |
Platelet-type bleeding disorder 8, Platelet-type bleeding disorder 8 |
| RS2473272655 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473272760 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Familial hypocalciuric hypercalcemia |
| RS2473272832 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473272943 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2473275307 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473275975 |
CASR
|
Health Risk |
Likely pathogenic |
CASR-related disorder, CASR-related disorder |
| RS2473276491 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473276542 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473276557 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Inborn genetic diseases |
| RS2473276800 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473277214 |
CASR
|
Health Risk |
Likely pathogenic |
— |
| RS2473277388 |
P2RY12
|
Health Risk |
Conflicting classifications of pathogenicity |
Platelet-type bleeding disorder 8, Platelet-type bleeding disorder 8 |
| RS2473277536 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473277634 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473277883 |
CASR
|
Health Risk |
Likely pathogenic |
CASR-related disorder, CASR-related disorder |
| RS2473278040 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2473279667 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2473280121 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473280480 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473280509 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2473281044 |
CASR
|
Health Risk |
Pathogenic |
Autosomal dominant hypocalcemia 1, Familial hypocalciuric hypercalcemia |
| RS2473281173 |
CASR
|
Health Risk |
Pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS2473281810 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
CASR-related disorder, Nephrolithiasis/nephrocalcinosis |
| RS2473281900 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS2473282291 |
SI
|
Health Risk |
Likely pathogenic |
SI-related disorder, SI-related disorder |
| RS2473282609 |
CASR
|
Health Risk |
Likely pathogenic |
Familial hypocalciuric hypercalcemia 1, Familial hypocalciuric hypercalcemia 1 |
| RS2473284144 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473288479 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473296292 |
SI
|
Health Risk |
Likely pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS2473296314 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS2473314623 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473317311 |
SI
|
Health Risk |
Likely pathogenic |
SI-related disorder, SI-related disorder |
| RS2473318061 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473327597 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473327728 |
ADCY5
|
Health Risk |
Pathogenic |
— |
| RS2473328198 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473328425 |
PLOD2
|
Health Risk |
Pathogenic |
— |
| RS2473328720 |
ATR
|
Health Risk |
Likely pathogenic |
— |
| RS2473342112 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473343738 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473347693 |
SI
|
Health Risk |
Likely pathogenic |
— |
| RS2473349464 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473350308 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473351517 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473354582 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2473355271 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473356749 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473357313 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2473357970 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2473358472 |
SI
|
Health Risk |
Pathogenic/Likely pathogenic |
Sucrase-isomaltase deficiency, Sucrase-isomaltase deficiency |
| RS2473367392 |
SLC7A14
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2473367671 |
ATR
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2473380542 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473381097 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473397144 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS2473397427 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2473398886 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473400519 |
COL4A4
|
Health Risk |
Likely pathogenic |
COL4A4-related disorder, COL4A4-related disorder |
| RS2473411186 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473418793 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473421946 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473425708 |
BCHE
|
Health Risk |
Likely pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS2473426112 |
BCHE
|
Health Risk |
Pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS2473426822 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS2473427253 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473429555 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473429687 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473432528 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473436419 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473438329 |
SI
|
Health Risk |
Pathogenic |
— |
| RS2473446366 |
ATR
|
Health Risk |
Pathogenic |
— |
| RS2473456927 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2473461451 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473466976 |
TTN
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Primary familial dilated cardiomyopathy |
| RS2473470274 |
SAMD7
|
Health Risk |
Pathogenic |
Macular dystrophy with or without cone dysfunction, Macular dystrophy with or without cone dysfunction |
| RS2473480338 |
SAMD7
|
Health Risk |
Pathogenic |
MACULAR DYSTROPHY WITH CONE DYSFUNCTION, MACULAR DYSTROPHY WITH CONE DYSFUNCTION |
| RS2473487440 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2473501928 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2473502883 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2473511125 |
PIK3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
PIK3CA related overgrowth syndrome, PIK3CA related overgrowth syndrome |
| RS2473511270 |
PIK3CA
|
Health Risk |
Likely pathogenic |
PIK3CA related overgrowth syndrome, PIK3CA related overgrowth syndrome |
| RS2473512064 |
IFT80
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS2473524076 |
PIK3CA
|
Health Risk |
Pathogenic |
PIK3CA related overgrowth syndrome, PIK3CA related overgrowth syndrome |
| RS2473553457 |
MED12L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2473557363 |
GHSR
|
Health Risk |
Likely pathogenic |
— |